Showing 5,701 - 5,720 results of 102,654 for search '(( 5 ((we decrease) OR (a decrease)) ) OR ( 50 ((nn decrease) OR (mean decrease)) ))', query time: 0.89s Refine Results
  1. 5701
  2. 5702
  3. 5703
  4. 5704
  5. 5705
  6. 5706
  7. 5707

    Efficacy and Acceptability of Glycemic Control of Glucagon-Like Peptide-1 Receptor Agonists among Type 2 Diabetes: A Systematic Review and Network Meta-Analysis by Zhixia Li (2736331)

    Published 2016
    “…Dulaglutide, exenatide long-acting release (exe_lar), liraglutide and taspoglutide had significant lowering effect when compared with sitagliptin (HbA1c<7.0%) and insulin (HbA1c<6.5%). Finally, according to SUCRAs, placebo, thiazolidinediones and albiglutide had the best decrease effect on hypoglycemia; sulphanylureas, sitagliptin and insulin decrease the incidence of treatment discontinuation most; exe_lar and dulaglutide had the highest impact on glycemic level among 13 treatments.…”
  8. 5708
  9. 5709
  10. 5710
  11. 5711
  12. 5712

    Ultrastructural defects of the epithelium in <i>Slc9a3</i><sup><i>–/–</i></sup>epididymis and vas deferens. by Ya-Yun Wang (175049)

    Published 2017
    “…(A, B) Caput epididymis. The arrow indicates the absence of stereocilia on the caput epithelium. …”
  13. 5713

    S2 File - by Alejandro Valencia (16007329)

    Published 2023
    “…Using the RAMP Hybrid method, we estimate 264,516 [95% confidence interval [CI], 223,506–307,577] premature deaths attributable to PM<sub>2.5</sub> from all sources, a ~1% overall decrease in CMAQ-estimated premature mortality compared to RAMP Hybrid, despite increases and decreases in some locations. …”
  14. 5714

    Analysis of the <sup>1</sup> H–<sup>15</sup>N HSQC spectrum of the RAGE V domain with unlabeled S100A1. by Md. Imran Khan (4853302)

    Published 2018
    “…Cross-peaks displaying significantly decreased intensity are shown in green boxes.</p> <p>(B) Bar graph analysis representing the intensity change (I/I<sub>0</sub>) of cross-peaks of <sup>15</sup>N V domain to <sup>15</sup>N V domain complex with S100A1 versus residue numbers of RAGE V domain (24–128). …”
  15. 5715

    Flow chart. by Raphaele Houlbracq (20558509)

    Published 2025
    “…The difference in overall prevalence of OASI between 2010 (0.7%) and 2021 (1.0%) was not statistically significant after adjustment (aRR 1.24, 95% CI 0.91 to 1.68). By groups of classification, the prevalence of OASI increased significantly only in Group 2b [nulliparous term cephalic singleton with spatula delivery] from 2.6% (95% CI 1.2 to 5.6) in 2010 to 9.6% (95% CI 6.2 to 14.7) in 2021 (aRR 3.69, 95% CI 1.50 to 9.09), and did not differ statistically significantly in Group 2a [nulliparous term cephalic singleton with forceps delivery] from 3.2% (95% CI 1.8 to 5.7) in 2010 to 5.7% (95% CI 3.4 to 9.5) in 2021 (aRR 1.78, 95% CI 0.81 to 3.90).…”
  16. 5716

    Minimal dataset. by Lilishia Gounder (15240167)

    Published 2024
    “…We obtained 7,639,978 HIV VL records from 736 healthcare facilities across KZN, of which 1,031,171 (13.5%) had detectable VLs (i.e., VLs ≥400 copies/millilitre (mL)). …”
  17. 5717

    Clinical characteristics of the study population. by Hun Gi Lee (21526538)

    Published 2025
    “…The proportions of emergency surgeries (46.5%), ICU admissions (36.5%), and unfavorable outcomes (21.5%) decreased. …”
  18. 5718
  19. 5719
  20. 5720